Stocks · News reference
8-K filing — TELA Bio, Inc. (TELA)
Filed: 2026-08-04 AccNo: 0001104659-26-090056 Size: 204 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 4, 2026, 11:08 AM
- Checked
- Aug 4, 2026, 11:08 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — TELA Bio, Inc. (TELA)
Filed: 2026-08-10 AccNo: 0001104659-26-093371 Size: 294 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarTELA Bio Q2 EPS $(0.20) Misses $(0.18) Estimate, Sales $19.291M Miss $20.008M Estimate
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 9.09 percent increase over losses of $(0.22) per share from the
Read original at benzingaTELA Bio shares are trading higher after the company announced the appointment of Heather Getz as its Chief Executive Officer and Director.
Read original at benzinga